NCT00262314View on ClinicalTrials.gov

Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients

CompletedOBSERVATIONAL
Enrollment

509

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

January 31, 2008

Study Completion Date

September 30, 2008

Conditions
Multiple Sclerosis
Trial Locations (1)

40504-3276

Registrat Inc, Lexington

Sponsors

Lead Sponsor

EMD Serono
All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT00262314 - Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients | Biotech Hunter | Biotech Hunter